zepbound tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide (Zepbound, Mounjaro): Weight Loss,

The economic impact extends beyond individual costs, with GLP-1 therapies driving 6.7% of total drug costs and representing about half of all drug spending increases in 2024 ^25

That way, it is easier to keep using this treatment for the best results

The results of the TRANSCEND-T2D-1 trial, published in March 2026, showed that participants with type 2 diabetes mellitus, who took retatrutide 12mg, lost an average of 16.8% of their body weight at 40 weeks

No: CL-SGTD-43 CAS No: NA Mol

Nestle, for instance, launched its Vital Pursuit frozen meal brand in late 2024, initially without a "GLP-1 Friendly" label, but added one after customer feedback